Oakridge Reports Increased Orders and $357K Cash Amid Expansion Efforts

Robust Growth in Healthcare Technology

Oakridge International Limited (ASX: OAK), an Australian leader in healthcare IoT solutions, has delivered a compelling quarterly update for the period ending 31 December 2024. The company’s latest Appendix 4C cash flow report and business update highlight substantial progress across sales, product development, and market expansion initiatives.

Central to Oakridge’s momentum is a marked increase in contracted orders, supported by a diversified project pipeline spanning multiple states. This growth underscores the company’s effective project management and national footprint in delivering nurse call and assistive technology solutions to hospitals, aged care, and disability sectors.

Innovation Driving Competitive Edge

Technological advancement remains a core pillar of Oakridge’s strategy. The company is enhancing its Nurse Call Management System (NuCaMS) with new features aimed at improving operational efficiency and reliability. Hardware improvements, including enhanced annunciator functionality and ongoing mobile app upgrades for Android and iOS platforms, reinforce Oakridge’s position as a market leader in mobile nurse call systems.

Looking ahead, Oakridge is investing in next-generation products such as Real-Time Location System (RTLS) integration and an enterprise version of NuCaMS. These innovations are designed to meet evolving healthcare demands and regulatory standards, including proactive compliance with the upcoming AS8311-2024 standards.

Strategic Partnerships and International Expansion

Oakridge continues to deepen relationships with its authorised partner network, leveraging partner and caregiver feedback to refine product offerings and drive sales growth. The company is actively pursuing new channel partners to broaden its distribution network and unlock new customer segments.

Internationally, Oakridge is progressing discussions to enter markets beyond Australia, including New Zealand, India, and the Middle East. This expansion strategy aims to diversify revenue streams and capture emerging opportunities in global healthcare technology markets.

Operational Strength and Financial Position

To support its growth trajectory, Oakridge is expanding its workforce by recruiting additional technical and administrative staff, ensuring capacity to meet rising demand while maintaining high service standards. Marketing efforts have also intensified, with enhanced digital presence and lead generation translating increased interest into tangible business opportunities.

Financially, the company reported a cash balance of $357,000 at quarter-end, down from $635,000 previously, with net operating cash outflows of $256,000 for the quarter. Oakridge acknowledges the need for additional funding and is evaluating options to secure further capital to sustain operations and growth initiatives.

Legal Considerations

Oakridge disclosed ongoing discussions related to a potential claim by Teko International Limited concerning alleged misrepresentations by previous directors. While the company recognizes possible exposure, it is actively engaging legal counsel and negotiating with Teko to mitigate risks and protect shareholder interests.

Outlook

With a robust project pipeline extending into 2025, continued product innovation, and strategic market expansion, Oakridge International is well-positioned for sustained growth in the healthcare technology sector. The company’s proactive approach to regulatory compliance and operational scaling further supports its leadership ambitions domestically and abroad.